FDA approves world's first RSV vaccine, a shot for adults ages 60 and up
Last edited Wed May 3, 2023, 02:01 PM - Edit history (1)
Source: NBC News
The Food and Drug Administration on Wednesday approved the world's first RSV vaccine: a shot for adults ages 60 and up, made by pharmaceutical giant GSK. The milestone was decades in the making. Researchers first attempted to develop a vaccine for respiratory syncytial virus roughly 60 years ago. In a late-stage clinical trial, the single-dose shot lowered the risk of symptomatic illness by 83% and of severe illness by 94%.
The Centers for Disease Control and Prevention must still recommend the vaccine before it becomes available to the public. A CDC advisory committee is scheduled to meet in June to discuss how the shot should be used. Dr. Phil Dormitzer, GSK’s senior vice president and global head of vaccines research and development, said the company is already manufacturing doses of the vaccine, to be sold under the brand name Arexvy.
“The goal is to have shots available in the fall so that people can get them before the next RSV season coming up late fall and winter,” Dormitzer said, though he did not give specific production numbers. RSV causes a lower respiratory illness that is typically mild for healthy adults. But in serious cases, the virus can lead to pneumonia or bronchiolitis, which inflames airways and clogs them with mucus.
Older people and infants are particularly at risk: RSV kills up to 10,000 people ages 65 or older and up to 300 children under 5 every year in the U.S. RSV cases typically peak between late December and mid-February, but cases last year started climbing in the summer as people left pandemic precautions behind.
Read more: https://www.nbcnews.com/health/health-news/fda-approves-rsv-vaccine-rcna82461
Article updated.
Original article -
The Centers for Disease Control and Prevention must still recommend the vaccine before it becomes available to the public. Dr. Phil Dormitzer, GSK’s senior vice president and global head of vaccines research and development, said the company is already manufacturing doses.
“The goal is to have shots available in the fall so that people can get them before the next RSV season coming up late fall and winter,” Dormitzer said, though he did not give specific production numbers.
RSV causes a lower respiratory illness that is typically mild for healthy adults. But in serious cases, the virus can lead to pneumonia or bronchiolitis, which inflames airways and clogs them with mucus. Older people and infants are particularly at risk: RSV kills up to 10,000 people ages 65 or older and up to 300 children under 5 every year in the U.S.
= new reply since forum marked as read
Fortunately I had someone in the house to take care of me, i.e. my husband. We did the home Covid test. The doc sent us out for curbside clinic Covid test. Nada. Hubby brought me the last bottle of Robitussin on the shelf at CVS, and while at Costco found a Kirkland generic expectorant product that really helped over time.
From Costco, comes in tablet form in bottles in a 2-pack. Label says:
Mucus Relief Chest/ Guaifenesin 400 mg/ Expectorant
Relieves chest congestion/ Thins and loosens mucus/ Makes coughs more productive
Per instructions I took 1 tablet every 4 hours when awake. The solid gunk at the bottom of my lungs started to move, and the cough gradually lessened in severity so I no longer felt like it would make me throw up.
Drank lots of hot tea, as one does. Stayed home. Thanked my lucky stars I am retired.
I am really sorry you are missing work, but take the time to get well. If you must go out, wear a mask to protect others and to protect yourself from catching something new while you are still recuperating. I do hope your school district is understanding about mask-wearing.
All the best to you. I hope some of this helps. 
is a DUzy!!! 
I just turned 60 in March and I'll be due for another booster. yay, shots!! 
